Description and Brand Names
Drug information provided by: IBM Micromedex
Descriptions
Caplacizumab-yhdp injection is used in combination with plasma exchange and immunosuppressive therapy (medicines to weaken the immune system) to treat acquired thrombotic thrombocytopenic purpura (aTTP).
This medicine is available only with your doctor's prescription.
Portions of this document last updated: March 01, 2019
Copyright © 2019 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.